Frontierby eninvs

Language: EN · RU

← Region

Mitra Keluarga Karyasehat (MIKA) USD

At a glance: strengths & risks
✓Revenue growing (+10%)✓Profit growing (+19%)✓Net cash balance sheet✓Cheaper than own history (EV/EBITDA 10.2 vs avg 14.9)

Sector: Healthcare

ID_MIKA

Price chart

1 845 IDRDay 1.10%

Key metrics

Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.

Market

Price
1 845 IDR · 1.10%
Market cap
1.5 bn USD

Growth

Δ revenue y/y
6.0%
Δ EBITDA y/y
8.5%

Multiples

P/E (LTM)
17.3x
3y avg: 24.4x
P/B (FY)
3.0x
P/E (ann.)
18.2x
EV/EBITDA (LTM)
10.2x
3y avg: 14.9x
EV/EBITDA (ann.)
10.5x

Cash return

Dividend yield
2.3%
FCF yield (LTM)
0.5%

Liquidity

Daily turnover (listing)
3.6 bln IDR

Shares: connector/market_inputs

Amounts: USD (converted) · As reported
Converted modes use NBK / ECB-linked rates: balance sheet date for BS items, period average for P&L and cash flow (see filing row evidence). As reported keeps each row in its filing currency.

Financial results

Monetary columns are in B USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.

DatePeriodStatusRevenueB USDOperating profitB USDD&AB USDEBITDAB USDNet profitB USDOperating CFB USDCapex + M&AB USDAssetsB USDEquityB USDROE (annualized)Net debtB USDSource
2026-06-30Q2 2026 (3M)PARTIAL0.1
y/y —
0.0
y/y —
0.0
y/y —
0.0
y/y —
0.0
y/y —
——0.6
y/y —
0.4
y/y —
18.6%-0.2Report (PDF)
2026-03-31Q1 2026 (3M)OK0.1
y/y 3.4%
0.0
y/y 1.2%
0.0
y/y 16.9%
0.0
y/y 3.9%
0.0
y/y 1.6%
0.0-237.40.6
y/y 8.3%
0.4
y/y 9.1%
16.5%-0.1Report (PDF)
2025-12-31Q4 2025 (3M)OK0.1
y/y 4.5%
0.0
y/y 4.4%
0.0
y/y -55.9%
0.0
y/y -15.3%
0.0
y/y 20.2%
0.0-373.50.6
y/y 8.8%
0.5
y/y 21.9%
17.3%-0.2Report (PDF)
2025-09-30Q3 2025 (3M)OK0.1
y/y 17.0%
0.0
y/y 33.2%
0.0
y/y 91.4%
0.0
y/y 39.5%
0.0
y/y 33.5%
0.0-219.30.5
y/y 2.6%
0.5
y/y 0.7%
6.6%-0.1Link
2025-06-30Q2 2025 (3M)OK0.1
y/y 4.3%
0.0
y/y 3.3%
0.0
y/y -2.3%
0.0
y/y 2.3%
0.0
y/y 3.1%
0.0-173.90.6
y/y 12.2%
0.5
y/y 10.1%
18.4%-0.1Link
2025-03-31Q1 2025 (3M)OK0.1
y/y -2.2%
0.0
y/y -3.3%
0.0
y/y 1.6%
0.0
y/y -2.5%
0.0
y/y 2.8%
0.0-208.50.5
y/y 6.7%
0.4
y/y 6.3%
18.8%-0.1Report (PDF)
2024-12-31Q4 2024 (3M)OK0.1
y/y —
0.0
y/y —
0.0
y/y —
0.0
y/y —
0.0
y/y —
0.0-209.40.5
y/y —
0.4
y/y —
16.7%-0.1Report (PDF)
2024-09-30Q3 2024 (3M)OK0.1
y/y 1.9%
0.0
y/y 2.1%
0.0
y/y -39.6%
0.0
y/y -5.0%
0.0
y/y -58.9%
0.0-142.50.5
y/y 13.5%
0.5
y/y 13.6%
5.2%-0.1Link
2024-06-30Q2 2024 (3M)OK0.1
y/y 9.4%
0.0
y/y 26.2%
0.0
y/y -62.2%
0.0
y/y -9.6%
0.0
y/y —
0.0-252.10.5
y/y 10.3%
0.4
y/y 2.8%
19.3%-0.1Link
2024-03-31Q1 2024 (3M)OK0.1
y/y —
0.0
y/y —
0.0
y/y —
0.0
y/y —
0.0
y/y —
0.0-94.50.5
y/y —
0.4
y/y —
18.2%-0.1Report (PDF)
2023-12-31Q4 2023 (3M)OK0.1
y/y —
0.0
y/y —
0.0
y/y —
0.0
y/y —
0.0
y/y —
0.0-12.70.5
y/y —
0.4
y/y —
14.2%—Link
2023-09-30Q3 2023 (3M)OK0.1
y/y —
0.0
y/y —
0.0
y/y —
0.0
y/y —
0.1
y/y —
0.0-76.10.5
y/y —
0.4
y/y —
13.8%—Link
2023-06-30Q2 2023 (3M)OK0.1
y/y —
0.0
y/y —
0.0
y/y —
0.0
y/y —
0.0
y/y —
0.0-68.60.4
y/y —
0.4
y/y —
——Link

Net debt structure (leases included, IFRS 16) 2026-06-30

Short-term debt (incl. ST leases)0
Long-term debt (incl. LT leases)0
− Cash & equivalents160
Net debt-159

Net debt / LTM EBITDA: -1.3x

Revenue & EBITDA

RevenueEBITDA

Quarterly values ($ mln)

0204060802024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q12026 q2

Year-over-year change

-20%0%20%40%60%2024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q12026 q2

Cash flow

FCF ($ mln)

-40-2002040602024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q12026 q2

Net debt / cash ($ mln)

-200-150-100-5002024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q12026 q2

Profit and cash

Profit is cash-backed
In a typical year of 2024–2025 operating cash flow came to 1.46x of reported net profit; after capex, 0.80x.
year20242025
cash flow / profit1.51x1.42x
accruals, % of assets-7.1%-6.2%
Last twelve months (to 2026-06-30): 0.23x of profit came back as operating cash flow.
net debt / EBITDA -0.8x · capex 2.5x of depreciation
● Over the last twelve months operating cash flow covered 23% of profit, against 1x across the annual window.
Read from the reported annual statements: cash flow / profit is the median of the yearly operating cash flow over net profit for the years shown; accruals are (profit − operating cash flow) / assets, the classic gap between what was booked and what was collected. A gap can be growth in working capital, capitalised costs, revaluations or profit from associates — the panel points at it, the statements explain it. Not investment advice.

Indonesia — currency context

USD/IDR17699
1-week-0.7%
1-month-1.4%
room to 52w-weakest2.8%
DXY (dollar index)99.0
US 10Y4.65%

A weaker rupiah lowers the USD value of Indonesian equities for a foreign holder; for banks, BI's high policy rate (defending the currency) pressures margins.

as of 2026-08-25 (Yahoo)

Dividends

Paid (completed)

DatePer shareDetailsStatusSource
2026-06-1943 IDREx-dividend: 43 IDR per sharePaidYahoo Finance (ex-div)
2025-06-1743 IDREx-dividend: 43 IDR per sharePaidYahoo Finance (ex-div)
2024-06-1334 IDREx-dividend: 34 IDR per sharePaidYahoo Finance (ex-div)
2023-06-0537 IDREx-dividend: 37 IDR per sharePaidYahoo Finance (ex-div)
2022-05-2336 IDREx-dividend: 36 IDR per sharePaidYahoo Finance (ex-div)

KASE: status follows wording in the news headline (paid vs intends to pay). Yahoo: amounts are cash dividends per share on ex-dividend dates (UTC calendar date). stockscope.uz (UZ): amounts are per share in UZS by publication date (not necessarily ex-div).

Investor reporting (IR): https://www.mitrakeluarga.com/investor-relations/

Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)

Financial results, valuation multiples (P/E, P/B, EV/EBITDA), profitability and dividend yield of Mitra Keluarga Karyasehat (MIKA) — from primary filings.

PT Mitra Keluarga Karyasehat Tbk owns and operates a network of hospitals in Indonesia, primarily located on Java, and also provides healthcare platform services.

Frequently asked questions

What is Mitra Keluarga Karyasehat (MIKA)'s P/E ratio?
Mitra Keluarga Karyasehat (MIKA) trades at a P/E of 17.3x (price to trailing 12-month earnings).
What is Mitra Keluarga Karyasehat (MIKA)'s EV/EBITDA?
Mitra Keluarga Karyasehat (MIKA) trades at 10.2x EV/EBITDA.
What is Mitra Keluarga Karyasehat (MIKA)'s P/B ratio?
Mitra Keluarga Karyasehat (MIKA) trades at a P/B of 3.0x.
What is Mitra Keluarga Karyasehat (MIKA)'s dividend yield?
Mitra Keluarga Karyasehat (MIKA)'s trailing 12-month dividend yield is 2.3%.
What is Mitra Keluarga Karyasehat (MIKA)'s return on equity (ROE)?
Mitra Keluarga Karyasehat (MIKA)'s ROE is 18.6%.
What is Mitra Keluarga Karyasehat (MIKA)'s market capitalization?
Mitra Keluarga Karyasehat (MIKA)'s market cap is 1.5 bn USD.

See also: Indonesian Stocks (2026): The Cheapest Big Emerging Market · The Cheapest Stocks in the World (2026): What Value Investing Says About Buying Cheap · global valuation map